Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 21, 2021
Patent Application Number
20210115
Date Filed
January 15, 2021
Patent Citations Received
Patent abstract
In one aspect, antibodies that specifically bind to a human triggering receptor expressed on myeloid cells 2 (TREM2) protein are provided. In some embodiments, the antibody decreases levels of soluble TREM2 (sTREM2). In some embodiments, the antibody enhances TREM2 activity.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
